Pacer Advisors, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$15.46 - $24.5 $57,372 - $90,919	-3,711 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$19.33 - $37.75 $11,443 - $22,348	-592 Reduced 13.76%	3,711 $86,000
Q4 2020 Jan 20, 2021	BUY	$24.48 - $42.47 $71,138 - $123,417	2,906 Added 208.02%	4,303 $106,000
Q3 2020 Oct 19, 2020	BUY	$39.09 - $53.44 $54,608 - $74,655	1,397 New	1,397 $58,000
Q4 2018 Feb 13, 2019	SELL	$85.79 - $126.46 $283,192 - $417,444	-3,301 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $292,105 - $421,042	3,301 New	3,301 $417,000
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $50,084 - $63,887	-950 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $66,115 - $82,655	-1,136 Reduced 54.46%	950 $55,000
Q3 2017 Nov 08, 2017	BUY	$57.01 - $118.75 $118,922 - $247,712	2,086	2,086 $121,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.